Clinical Study
A Combined Therapy with Myo-Inositol and D-Chiro-Inositol Improves Endocrine Parameters and Insulin Resistance in PCOS Young Overweight Women
Table 2
Baseline and posttreatment endocrine and metabolic parameters of groups A and B of PCOS patients.
| | Group A () | Group B () | | Baseline | MI plus DCI | p value | Baseline | placebo | value |
| FSH (mIU/mL) | 5.86 ± 1.75 | 4.96 ± 1.74 | ns | 5.67 ± 1.11 | 5.47 ± 0.63 | ns | LH (mIU/mL) | 12.5 ± 8 | 8.5 ± 4.04 | | 11.27 ± 7.2 | 11.25 ± 5.35 | ns | E (pg/mL) | 47.06 ± 18.20 | 107.42 ± 92.86 | | 50.37 ± 19.45 | 52 ± 20.2 | ns | Fasting insulin (μU/mL) | 20.19 ± 8.14 | 10.74 ± 5.46 | | 18 ± 8 | 17.8 ± 8.2 | ns | Fasting glucose (mg/dL) | 85 ± 5.96 | 86 ± 7.12 | ns | 86.2 ± 9.1 | 84.73 ± 8.3 | ns | Free testosterone (ng/dL) | 0.76 ± 0.20 | 0.62 ± 0.15 | | 0.85 ± 0.22 | 0.83 ± 0.2 | ns | SHBG (nmol/L) | 24.11 ± 10.35 | 35.85 ± 24.3 | | 20.44 ± 8.77 | 21.36 ± 7.57 | ns | Androstenedione (ng/mL) | 4.25 ± 1.48 | 4.01 ± 1.70 | ns | 3.48 ± 1.21 | 3.12 ± 2.23 | ns | DHEAS (μg/dL) | 327.32 ± 150.89 | 347.6 ± 170.98 | ns | 337.95 ± 155.79 | 315.83 ± 145.59 | ns | HOMA | 3.38 ± 1.97 | 1.97 ± 1.48 | | 3.48 ± 2.02 | 2.8 ± 1.4 | ns |
|
|
E, 17-beta-Estradiol; P, progesterone; 17OHP, 17-OH-progesterone; SHBG, Sex Hormone Binding Globulin; DHEAS, dehydroepiandrosterone sulphate.
|